TransCon PTH

Designed to replace parathyroid hormone to physiologic levels in patients with hypoparathyroidism

Designed to replace parathyroid hormone to physiologic levels in patients with hypoparathyroidism

Vector-Smart-Object-copy

A survey of people living with hypoparathyroidism (N=146) showed patients required multiple physician visits and up to one decade to diagnose their condition.

Explore

You are about to access www.ascendispharma.us.
The information on this website is intended for residents of the United States. Click below to confirm you are a citizen and/or resident of the United States.

GO